These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4157148)

  • 1. [Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601].
    Marchetti G; Merlo L; Noseda V
    Boll Soc Ital Cardiol; 1973; 18(7):672-5. PubMed ID: 4157148
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of beta-blocking drugs on myocardial consumption of free fatty acids and carbohydrates].
    Marchetti G; Merlo L; Noseda V
    Atti Soc Ital Cardiol; 1968; 2():182-4. PubMed ID: 5717502
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nonselective and cardioselective beta-adrenergic blockade on fatty acid metabolism in the myocardium].
    Abidova SS; Ovchinnikov IV; Gimmel'farb GN
    Farmakol Toksikol; 1987; 50(5):29-31. PubMed ID: 2891565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of nitroglycerin and of the combination of nitroglycerin and beta inhibitors on systemic and coronary hemodynamics and on cardiac metabolism].
    Marchetti GV; Merlo L; Brusoni B
    Boll Soc Ital Cardiol; 1975; 20(10):1197-205. PubMed ID: 10931
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of a new adrenergic beta-blocking agent, Kö 1400 on the canine heart-lung preparation supported by a donor dog and the perfused hindlimb preparation of the dog (author's transl)].
    Nakagawa Y; Takeda K; Katano Y; Tsukada T; Matsubara I
    Nihon Yakurigaku Zasshi; 1977 May; 73(4):411-21. PubMed ID: 20393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system].
    Takenaka F; Ishihara T; Maruyama Y; Matsumoto S; Inoue H
    Nihon Yakurigaku Zasshi; 1974 May; 70(3):385-97. PubMed ID: 4155394
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of beta-adrenolytic properties of N,N'-bis-(3-(p-methoxyphenoxy)-2-hydroxypropyl)-ethylenediamine and its N,N'-dimethyl derivative.
    Robak J; Grodzińska L
    Pol J Pharmacol Pharm; 1973; 25(3):253-7. PubMed ID: 4150018
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of dl-propranolol on myocardial free fatty acid and carbohydrate metabolism.
    Masters TN; Glaviano VV
    J Pharmacol Exp Ther; 1969 May; 167(1):187-93. PubMed ID: 5772747
    [No Abstract]   [Full Text] [Related]  

  • 9. [Automatic evaluation of thoracic and epicardic electromaps in experimental acute infarct. Effect of a new beta-moderating drug on the extent of the ischemic area].
    Taccadi B; Macchi E; De Ambroggi L
    Boll Soc Ital Cardiol; 1975; 20(10):1293-302. PubMed ID: 10932
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46)].
    Hammerl H; Kränzl C; Nebosis G; Pichler O; Studlar M
    Arzneimittelforschung; 1972 Jun; 22(6):1055-61. PubMed ID: 4403217
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pharmacology of the optically active isomers of talinolol (cordanum) 2].
    Femmer K; Poppe H
    Pharmazie; 1982 Jul; 37(7):505-8. PubMed ID: 6127726
    [No Abstract]   [Full Text] [Related]  

  • 13. Proceedings: Antagonism by ICI 66082 of the effects of electrical stimulation on the right ansa subclavia of the dog.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Mar; 50(3):457P-458P. PubMed ID: 4153012
    [No Abstract]   [Full Text] [Related]  

  • 14. The inhibitory effect of bevantolol on the accumulation of non-esterified fatty acids during ischaemia in the dog heart in situ.
    Miura I; Nasa Y; Ichihara K; Abiko Y
    Clin Exp Pharmacol Physiol; 1991 Apr; 18(4):259-62. PubMed ID: 1676940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of trimepranol on the binding of [3H] norepinephrine in myocardial subcellular fractions of the dog.
    Nedvídková J; Felt V
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):208-11. PubMed ID: 9036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of 1-phenylaminoethylamino-3-(phenoxy)propanol derivatives with beta-adrenergic action].
    Femmer K; Heer S; Poppe H
    Pharmazie; 1983 Jun; 38(6):409-14. PubMed ID: 6136994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR; Vyas DS
    Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of bunitrolol on myocardial metabolism of free fatty acids (FFA) in angina patients].
    Masi M; Cuccurullo F; Rosini R; Mezzetti A; Fontana F; Luciani G; Lenzi S
    Boll Soc Ital Cardiol; 1977; 22(11):2103-12. PubMed ID: 38819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of adrenergic stimulation of cardiac activity on myocardial consumption of free fatty acids and triglycerides].
    Gereliuk IP
    Fiziol Zh SSSR Im I M Sechenova; 1981 Jul; 67(7):1035-9. PubMed ID: 7286318
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of free fatty acids on myocardial oxygen consumption and ischemic injury.
    Vik-Mo H; Mjøs OD
    Am J Cardiol; 1981 Aug; 48(2):361-5. PubMed ID: 6115579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.